Transaction in Own Shares
Rhea-AI Summary
Shell (SHEL) announced on 19 January 2026 that it purchased shares for cancellation as part of its ongoing buy-back programme announced on 30 October 2025.
Aggregated purchases that day:
- 659,305 shares on LSE at VWAP £27.3701
- 661,777 shares on XAMS at VWAP €31.6718
Positive
- Purchased 659,305 shares on LSE (VWAP £27.3701) for cancellation
- Purchased 661,777 shares on XAMS (VWAP €31.6718) for cancellation
- Buy-back programme continues under authorised on- and off-market mechanisms
Negative
- No aggregate total share count or percentage of share capital disclosed for the day
- Purchases limited to two venues with other venues showing no trades that day
Key Figures
Market Reality Check
Peers on Argus
SHEL gained 1.13% while peers were mixed: CVX -0.2%, BP -0.08% versus XOM +0.75%, TTE +0.55%, PBR +0.48%, indicating company-specific drivers rather than a uniform sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 13 | Share buy-back | Positive | +2.1% | Disclosure of 1.68M shares repurchased and cancelled across LSE and XAMS. |
| Jan 12 | Share buy-back | Positive | +1.2% | Update on 1.96M shares bought back under existing repurchase programme. |
| Jan 09 | Share buy-back | Positive | +0.7% | Report of 2.09M shares repurchased across several trading venues. |
| Jan 08 | Share buy-back | Positive | -1.7% | Disclosure of 2.43M shares repurchased as part of ongoing buy-back. |
| Jan 08 | Q4 2025 update | Negative | -1.7% | Q4 outlook with below break-even Chemicals and large German cash outflows. |
Recent buy-back disclosures have generally coincided with modest positive price reactions, with one notable negative day, while the Q4 update also saw a negative move.
This announcement continues Shell’s active share repurchase pattern under programmes disclosed since 2025. Prior January 2026 buy-back reports on 8–13 Jan detailed daily cancellations of roughly 1.7–2.4 million shares across UK and European venues, with Merrill Lynch executing independently within preset parameters and under UK MAR/EU MAR rules. Those buy-back updates mostly aligned with positive single-day price moves. By contrast, the 8 Jan 2026 Q4 2025 update, which highlighted below break-even Chemicals performance and sizeable German-related cash outflows, coincided with a negative price reaction.
Market Pulse Summary
This announcement details another day of on- and off-market share repurchases for cancellation under Shell’s existing programme, with specific volumes and prices reported for LSE and XAMS on 19 January 2026. It extends a sequence of January 2026 buy-back disclosures that have steadily reduced share count. The activity is executed by Merrill Lynch within preset parameters and conducted under UK MAR and EU MAR rules. Observers may track ongoing daily volumes, programme timelines through 30 January 2026, and how these interact with upcoming results and prior Q4 guidance.
Key Terms
eu mar regulatory
uk mar regulatory
off-market buyback contract financial
AI-generated analysis. Not financial advice.
Transaction in Own Shares
19 January, 2026
• • • • • • • • • • • • • • • •
Shell plc (the ‘Company’) announces that on 19 January, 2026 it purchased the following number of Shares for cancellation.
Aggregated information on Shares purchased according to trading venue:
| Date of purchase | Number of Shares purchased | Highest price paid | Lowest price paid | Volume weighted average price paid per share | Venue | Currency |
| 19/01/2026 | 659,305 | 27.6000 | 27.2700 | 27.3701 | LSE | GBP |
| 19/01/2026 | - | - | - | - | Chi-X (CXE) | GBP |
| 19/01/2026 | - | - | - | - | BATS (BXE) | GBP |
| 19/01/2026 | 661,777 | 31.9000 | 31.5400 | 31.6718 | XAMS | EUR |
| 19/01/2026 | - | - | - | - | CBOE DXE | EUR |
| 19/01/2026 | - | - | - | - | TQEX | EUR |
These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 30 October 2025.
In respect of this programme, Merrill Lynch International will make trading decisions in relation to the securities independently of the Company for a period from 30 October 2025 up to and including 30 January 2026.
The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.
In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Merrill Lynch International on behalf of the Company as a part of the buy-back programme is detailed below.
Enquiries
Media: International +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html
Attachment